Inspire Medical Systems, Inc. (INSP): R&D Expense
$103.17M
Year ended 2025-12-31
$99.68M
Trailing 12 months to 2026-06-30
+14.5%
3-year compound annual growth
+31.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $103.17M | -9.6% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $114.13M | -2.1% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $116.54M | +69.8% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $68.64M | +83.8% | 2025-02-10, From 2022-01-01 |
| 2021-12-31 | $37.35M | +43.1% | 2024-02-09, From 2021-01-01 |
| 2020-12-31 | $26.09M | +103.2% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $12.84M | +73.8% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $7.39M | +19.3% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $6.19M | -12.6% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $7.09M | n/a | 2019-02-26, From 2016-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| Embecta Corp. (EMBC) | 2025-09-30 | $37.30M | -52.7% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| Haemonetics Corp (HAE) | 2026-03-28 | $59.77M | -4.7% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
Compare INSP, OFIX, TNDM, EMBC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗